A. Oliver Sartor, MD
Tulane Cancer Center
New Orleans, Louisiana
Dr. Oliver Sartor received his medical degree from Tulane University School of Medicine, New Orleans, Louisiana. After a pediatric internship at Children’s Hospital of Philadelphia, University of Pennsylvania, he trained in internal medicine at Tulane University School of Medicine. After completing his fellowship in medical oncology at the National Cancer Institute (NCI) in Bethesda, Maryland, Dr. Sartor served as a senior investigator at the NCI where he began focusing on novel therapeutics for advanced prostate cancer patients. He is currently C.E. and Bernadine Laborde Professor of Cancer Research and medical director at Tulane Cancer Center.
Dr. Sartor’s interests have focused broadly on prostate cancer, predominantly in those patients who failed initial therapies. He has published over 100 scholarly articles ranging from genetic studies on prostate cancer to clinical trials involving novel agents. He has been a lead author on pivotal studies for FDA drug approval in prostate cancer, and has been the principal investigator on a number of prospective international clinical trials evaluating new therapies for patients with advanced prostate cancer. In addition, Dr. Sartor is the medical oncology co-chair of the Radiation Therapy Oncology Group (RTOG) Genitourinary Committee, is co-editor in chief of Clinical Genitourinary Cancer, and has served as chairman of the Department of Defense Prostate Cancer Integration Panel.